Diabetes Medication May Lead To Diabetic Ketoacidosis, Renal Failure, Cardiovascular Risks, Heart Attack and Stroke
Invokana, also known as canagliflozin, is a type two diabetes medication. It is used along with diet and exercise in order to reduce blood sugar.
How does it work?
Invokana deals with excess blood sugar through utilizing a “short-circuit solution”. The drug does not metabolize sugar, but instead brings all of the body’s glucose to the kidneys and blocks reabsorption. This is an unnatural emergency mechanism which can overload the kidneys. Additionally, the body has no sugar to utilize for energy so it cannibalizes and pulls sugar from glucose found in both fat and muscle.
What complications have resulted from usage?
Invokana has recently been linked with diabetic ketoacidosis and osteoporosis. Diabetic ketoacidosis is a serious diabetes complication where the body produces excess blood acids (ketones). This can then lead to renal failureand various cardiovascular risks. Osteoporosis decreases bone strength and increases the risk of broken bones. Heart attack and stroke are other potential side effects not noted on the warning labels of the product.
How do I know if I have diabetic ketoacidosis?
The FDA recommends that people taking these prescriptions look for symptoms of ketoacidosis including difficulty breathing, vomiting, nausea, confusion, unusual fatigue, or abdominal pain. If you have experienced any of these symptoms, you should seek emergency medical treatment.
Contact an Experienced Attorney – Get a Free Case Evaluation
With over three decades of experience, the law firm of Rudolph F.X. Migliore, P.C. is positioned to help those who have been harmed by these medications. Our law firm works with nationally recognized associated firms to reach major verdicts and settlements. Call our New York office at (631) 543-3663 to arrange a no cost, no obligation consultation to find out how an attorney can help you.